Cortex Pharmaceuticals, Inc.

United States of America

 
Total IP 7
Total IP Rank # 220,795
IP Activity Score 0/5.0    0
IP Activity Rank # 1,661,095

Patents

Trademarks

0 0
0 0
7 0
0
 
Last Patent 2010 - 3-substituted-1,2,3-triazin-4-on...
First Patent 1991 - Use of calpain inhibitors in the...

Latest Inventions, Goods, Services

2010 Invention Bicyclic amide derivatives for the treatment of respiratory depression. This invention relates to...
Invention Bicyclic amide derivatives for enhancing glutamatergic synaptic responses. This invention relates...
2008 Invention 3-substituted-1,2,3-triazin-4-one's and 3 substituted 1,3-pyrimidinone's for enhancing glutamater...
Invention 3-substituted 1,2,3-triazin-4-one's and 3-substituted 1,3-pyrimidinone's for enhancing glutamater...
Invention Bicyclic amides for enhancing glutamatergic synaptic responses. This invention relates to pharmac...
Invention Bicyclic amides for ehancing glutamatergic synaptic responses. This invention relates to compound...
Invention Bicyclic amides for enhancing glutamatergic synaptic responses. This invention relates to compoun...
Invention Di-substituted amides for enhancing glutamatergic synaptic responses. This invention relates to c...
2007 Invention 3-substituted-[1,2,3]-benzotriazinone compounds for enhancing glutamatergic synaptic responses. ...
Invention 3-substituted-[1,2,3]benzotriazinone compounds for enhancing glutamatergic synaptic responses. Th...
Invention 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses. Th...
2005 Invention Enhancement of ampakine-induced facilitation of synaptic responses by cholinesterase inhibitors. ...
2004 Invention Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses. This invention rela...
Invention Method of treating cognitive decline due to sleep deprivation and stress. This invention relates ...
1998 Invention Benzoxazine compounds for enhancing synaptic response. Compounds having a certain benzoxazine rin...
Invention Treatment of schizophrenia with ampakines and neuroleptics. This invention relates to treatment o...
Invention Benzofurazan compounds which enhance ampa receptor activity. Compounds of general structural form...
1997 Invention Benzoxazines for enhancing synaptic response. Compounds of formula (I) in which R?1 and R2¿ are i...
1996 Invention Benzoyl piperidines/pyrrolidines for enhancing synaptic response. Benzoyl piperidines and pyrroli...
Invention Benzoxazines for enhancing synaptic response. Compounds based on the benzoxazine ring system ##ST...
1995 Invention Use of metabotropic receptor agonists in progressive neurodegenerative diseases. A method of trea...
1994 Invention Alkaline and acid phosphatase inhibitors in treatment of neurological disorders. The present inve...
Invention Use of metabotropic receptor agonists in progressive neurodegenerative deseases. A pharmaceutical...
1993 Invention Optically pure calpain inhibitor compounds. Optically pure .alpha.-ketoamide compounds, and use t...
Invention Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with i...
1991 Invention Use of calpain inhibitors in the inhibition and treatment of neurodegeneration. The present inven...
Invention Use of calpain inhibitors in the inhibition and treatment of neurodegeneration. 2098609 9211850 P...